First Time Loading...

RVL Pharmaceuticals PLC
NASDAQ:RVLP

Watchlist Manager
RVL Pharmaceuticals PLC Logo
RVL Pharmaceuticals PLC
NASDAQ:RVLP
Watchlist
Price: 0.0024 USD 14.29% Market Closed
Updated: May 7, 2024

Wall Street
Price Targets

RVLP Price Targets Summary
RVL Pharmaceuticals PLC

There are no price targets for RVLP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
RVL Pharmaceuticals PLC Competitors:
Price Targets
NEULANDLAB
Neuland Laboratories Ltd
15% Upside
SWDCF
Swedencare AB (publ)
21% Upside
053030
Binex Co Ltd
9% Upside
KILITCH
Kilitch Drugs (India) Ltd
38% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
12% Upside
ITCI
Intra-Cellular Therapies Inc
32% Upside
ANCR
Animalcare Group PLC
27% Upside
243070
Huons Co Ltd
70% Upside

Revenue
Forecast

Revenue Estimate
RVL Pharmaceuticals PLC

For the last 5 years the compound annual growth rate for RVL Pharmaceuticals PLC's revenue is -27%. The projected CAGR for the next 2 years is 4%.

-27%
Past Growth
4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
RVL Pharmaceuticals PLC

Operating Income forecast
is not available for
RVL Pharmaceuticals PLC

Net Income
Forecast

Net Income Estimate
RVL Pharmaceuticals PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RVLP's stock price target?
Not Available

RVLP doesn't have any price targets made by Wall Street professionals.

What is RVL Pharmaceuticals PLC's Revenue forecast?
Projected CAGR
4%

For the last 5 years the compound annual growth rate for RVL Pharmaceuticals PLC's revenue is -27%. The projected CAGR for the next 2 years is 4%.